Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale)-Reference-Cited by-同舟云学术

Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale)

Published:2006-06 Issue: Volume:17 Page:vii15-vii17
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Lorusso V.,Spada M.,Giampaglia M.,Misino A.,Calabrese R.,Latorre A.,Monticelli G.,Guida M.,Sambiasi D.,Colucci G.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/suppl_7/vii15/346901/mdl942.pdf

Reference22 articles.

1. Cancer: Principles and Practice of Oncology;De Vita,1993

2. Systemic therapy for advanced breast cancer;Tripathy;Breast J,2004

3. Progress in chemotherapy for metastatic breast cancer;Sledge;Sem Oncol,1992

4. The effect on survival of initial chemotherapy in advanced breast cancer. Polychemotherapy versus single drug;Ahmann;J Clin Oncol,1987

5. Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial;Jassem;J Clin Oncol,2001

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inetetamab combined with pyrotinib and oral vinorelbine for patients with human epidermal growth factor receptor 2 positive advanced breast cancer: A single-arm phase 2 clinical trial;Cancer Pathogenesis and Therapy;2024-01

2. Vinorelbine After Prior Treatment With Eribulin for Advanced Breast Cancer: A Single-Centre Experience Suggesting Cross-Resistance;Clinical Breast Cancer;2022-10

3. A Real-World Study on Oral Vinorelbine for the Treatment of Metastatic Breast Cancer;Oncologie;2022

4. A Critical Appraisal of Current Status of Synthetic Antioxidant Molecules in the Treatment of Breast Cancer;Handbook of Oxidative Stress in Cancer: Therapeutic Aspects;2022

5. A Critical Appraisal of Current Status of Synthetic Antioxidant Molecules in the Treatment of Breast Cancer;Handbook of Oxidative Stress in Cancer: Therapeutic Aspects;2022